Researchers have gained new insights into the syphilis genome to aid in vaccine design. Syphilis cases are the highest they have been in over 70 years, leading public health officials to seek new ways ...

We foresee that a candidate vaccine for syphilis will be under evaluation in the next 10 years. It is unlikely that we will ever eradicate syphilis infection but we will have learnt much from this ...

The Centers for Disease Control and Prevention took offline recommendations on how doctors should treat sexually transmitted ...

A team of researchers, led by University of Victoria microbiologist Caroline Cameron, is now developing a vaccine for syphilis, using a new chain of amino acids composed of portions of multiple ...

Because of that fragility, researchers have been limited in their ability to develop new syphilis diagnostics, treatments, and preventive measures such as vaccines. Effective treatments are ...

and to support initial research into three new vaccines for E. coli, herpes and syphilis. Announced today, the grant is funded by Washington’s $350 million tobacco-lawsuit-settlement bonus and ...

Opens in a new tab or window Three main factors contributed to COVID vaccine hesitancy among Black ... with examples including the Tuskegee Syphilis Study and the case of Henrietta Lacks, the ...

These animals are expensive, but they will bring Dr. Deacon closer to man than any other syphilis vaccine researcher yet. Untreated Million. Lest anyone doubt the severity of the syphilis problem ...

He eventually surprised colleagues by leaving the potentially profitable field of serology (developing antitoxins and vaccines that ... the one which causes syphilis. At that time, syphilis ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well-being of all.

Efforts to develop a safe and effective syphilis vaccine have been hindered by our lack of knowledge of the relative importance of humoral and cellular immunity.